Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 and Pharmacokinetic Single Agent Study of Romidepsin in Patients With, Lymphomas, Chronic Lymphocytic Leukemia, and Select Solid Tumors and Varying Degrees of Liver Dysfunction

Next Previous
Search
Trial Profile

A Phase 1 and Pharmacokinetic Single Agent Study of Romidepsin in Patients With, Lymphomas, Chronic Lymphocytic Leukemia, and Select Solid Tumors and Varying Degrees of Liver Dysfunction

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 10 Feb 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Romidepsin (Primary)
  • Indications Adenocarcinoma; Advanced breast cancer; Biliary cancer; Bladder cancer; Carcinoma; Chronic lymphocytic leukaemia; Colorectal cancer; Cutaneous T-cell lymphoma; Glioma; Gynaecological cancer; Head and neck cancer; Leukaemia; Liver cancer; Lung cancer; Lymphoma; Malignant melanoma; Mesothelioma; Non-Hodgkin's lymphoma; Oropharyngeal cancer; Pancreatic cancer; Peripheral T-cell lymphoma; Prostate cancer; Renal cell carcinoma; Skin cancer; Soft tissue sarcoma; Solid tumours; Thyroid cancer; Urogenital cancer
  • Focus Adverse reactions; Pharmacokinetics

    • Most Recent Events

    • 07 Feb 2025 Status changed from active, no longer recruiting to completed.
    • 06 Mar 2024 Planned End Date changed from 30 Jun 2018 to 5 Mar 2025.
    • 14 Aug 2020 Results published in the Clinical Cancer Research

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top